1. Home
  2. CRVS vs BHRB Comparison

CRVS vs BHRB Comparison

Compare CRVS & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$66.87

Market Cap

968.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
BHRB
Founded
2014
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
968.8M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
CRVS
BHRB
Price
$12.68
$66.87
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$30.17
$71.80
AVG Volume (30 Days)
1.3M
175.2K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
3.46%
EPS Growth
48.04
173.76
EPS
N/A
1.79
Revenue
N/A
N/A
Revenue This Year
N/A
$36.62
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
$36.58
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$56.35
52 Week High
$26.95
$70.90

Technical Indicators

Market Signals
Indicator
CRVS
BHRB
Relative Strength Index (RSI) 52.58 61.54
Support Level $11.13 $61.25
Resistance Level $14.00 $67.53
Average True Range (ATR) 0.66 1.50
MACD 0.24 0.12
Stochastic Oscillator 83.26 86.58

Price Performance

Historical Comparison
CRVS
BHRB

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: